Results 201 to 210 of about 312,077 (256)
Abstract Aims This work assessed the pharmacokinetics (PK), safety and tolerability of glasmacinal (EP395, an oral anti‐inflammatory macrolide with negligible antimicrobial activity in development for COPD treatment) in two healthy participant trials: ‘first‐in‐human’ (FIH) and ‘drug–drug‐interaction’ (DDI).
Dave Singh +5 more
wiley +1 more source
Risk prediction for secondary pulmonary fungal infection during acute exacerbation of chronic obstructive pulmonary disease. [PDF]
Wu X, Li J, Wang H.
europepmc +1 more source
Multimodal Therapeutic Strategies for the Management of Sarcopenia and Frailty in Chronic Obstructive Pulmonary Disease: A Narrative Review. [PDF]
Naas S +10 more
europepmc +1 more source
Healthcare professionals' challenges and solutions in providing palliative care to patients with severe chronic obstructive pulmonary disease. [PDF]
McCarthy S +6 more
europepmc +1 more source
Temporal trends in stroke-prevention medication use in patients with atrial fibrillation and chronic obstructive pulmonary disease. [PDF]
Shen CW +5 more
europepmc +1 more source
Prediction of chronic obstructive pulmonary disease based on multimodal data and deep learning. [PDF]
Deng H, Ding X, Zhu S, Song X, Guo Y.
europepmc +1 more source

